High-Dose Chemotherapy and Autologous Stem Cell Transplant

This article reviews the current knowledge on high-dose chemotherapy (HDCT) and stem cell transplant for salvage treatment of patients with relapsed metastatic GCT. Furthermore, the authors attempt to dissect the controv ersy of using standard-dose versus high-dose therapy as initial salvage and identify patients who are most likely to benefit from HDCT and peripheral blood stem cell transplant.
Source: Urologic Clinics of North America - Category: Urology & Nephrology Authors: Source Type: research